Federal Register / Vol. 60, No. 33 / Friday, February 17, 1995 / Notices 9333

Dated: February 14, 1995.

William D. Dickerson,

Director, Federal Agency Liaison Division,

Office of Federal Activities.

[FR Doc. 95–4039 Filed 2–16–95; 8:45 am]

BILLING CODE 6560–50–U

[ER-FRL–4720–3]

Environmental Impact Statements;

Notice of Availability

Responsible Agency: Office of Federal

Activities, General Information (202)

260–5076 OR (202) 260–5075. Weekly

receipt of Environmental Impact

Statements Filed February 06, 1995

Through February 10, 1995 Pursuant to

40 CFR 1506.9.

EIS No. 950043, DRAFT EIS, NPS, FL,

Timucuan Ecological and Historic

Preserve, General Management Plan

and Development Concept Plans,

Implementation, Fort Caroline

National Memorial Area, Duval

County, FL, Due: April 10, 1995,

Contact: Suzanne Lewis (904) 221–

5568.

EIS No. 950044, DRAFT EIS, FRC, VT,

Clyde River Hydroelectric (FERC No.

23306) Project, New License

(Relicense) for three Hydroelectric

Developments, Construction and

Operation, Clyde River within the St.

Lawrence River Basin, Orleans

County, VT, Due: April 18, 1995,

Contact: Kathleen Sherman (202) 219–

2834.

EIS No. 950045, FINAL SUPPLEMENT,

COE, FL, Palm Beach County Beach

Erosion Project, Updated Information,

Shore Protection Project, Jupiter/

Carlin Segment from Martin Co., Line

to Lake Worth Inlet and from South

Lake Worth Inlet to Broward General

Design Plan, Implementation, Martin

and Broward Counties, FL, Due:

March 20, 1995, Contact: Michael

Dupes (904) 232–1689.

EIS No. 950046, DRAFT EIS, BLM, MT,

Sweet Grass Hills Resource

Management Plan Amendment,

Implementation, West HiLine

Resource Management Plan, Toole

and Liberty Counties, MT, Due: May

18, 1995, Contact: James Beaver (406)

255–2910.

EIS No. 950047, DRAFT EIS, BPA, WA,

OR, WA, Resource Contingency

Program, Construction and Operation,

Three Proposed Plant Sites, Chelalis

Hermiston and Satsop Power Projects,

Lewis and Grays Harbor Counties,

WA and Washington and Umattilla

Counties, OR, Due: April 03, 1995,

Contact: Dawn Boorse (503) 230–

5678.

Amended Notices

EIS No. 940501, DRAFT EIS, AFS, ID,

Stibnite Gold Mine Expansion Project,

Construction and Operation, Plan of

Operation Approval, NPDES Permit

and COE Section 404 Permit, Payette

National Forest, Krassel Ranger

District, Valley County, ID, Due:

February 14, 1995, Contact: Jane

Wurster (206) 634–0614. Published

FR -12–16–94 Review period

extended.

Dated: February 14, 1995.

William D. Dickerson,

Director, Federal Agency Liaison Div., Office

of Federal Activities.

[FR Doc. 95–4038 Filed 2–16–95; 8:45 am]

BILLING CODE 6560–50–U

[FRL–5156–1]

Economic Incentive and Regulatory

Innovation Subcommittee of the Clean

Air Act Advisory Committee

AGENCY: Environmental Protection

Agency.

ACTION: Notice of open meeting.

SUMMARY: Pursuant to the Federal

Advisory Committee Act, Public Law

92–463, notice is hereby given that the

Environmental Protection Agency is

convening an open meeting of the

Economic Incentive and Regulatory

Innovation Subcommittee of the Clean

Air Act Advisory Committee on March

3, 1995. This meeting will concern the

development of generic language for a

rule on emissions trading. The meeting

is open to the public. Seating will be

available on a first-come, first-served

basis.

DATES: The Subcommittee will meet on

March 3, 1995. The meeting will begin

at approximately 9 a.m. EST and run

until about 1 p.m.

ADDRESSES: The Subcommittee will

meet in conference room #3 North

located in EPA Headquarters, 401 M

Street, SW, Washington, DC 20460.

FOR FURTHER INFORMATION CONTACT:

Carey Fitzmaurice, US EPA (202) 260–

7433 or Scott Mathias, US EPA–OAQPS

(919) 541–5310.

Dated: February 9, 1995.

John S. Seitz,

Director, Office of Air Quality Planning and

Standards.

[FR Doc. 95–4050 Filed 2–16–95; 8:45 am]

BILLING CODE 6560–50–M

FEDERAL MARITIME COMMISSION

Notice of Agreement(s) Filed

The Federal Maritime Commission

hereby gives notice that the following

agreement(s) has been filed with the

Commission for approval pursuant to

section 15 of the Shipping Act, 1916, as

amended (39 Stat. 733, 75 Stat. 763, 46

U.S.C. § 814).

Interested parties may inspect and

may request a copy of each agreement

and the supporting statement at the

Washington, D.C. Office of the Federal

Maritime Commission, 1100 L Street,

N.W., Room 10325. Interested parties

may submit protests or comments on

each agreement to the Secretary, Federal

Maritime Commission, Washington,

D.C. 20573, within 10 days after the date

of the Federal Register in which this

notice appears. The requirements for

comments and protests are found in

§ 560.7 of Title 46 of the Code of Federal

Regulations. Interested persons should

consult this section before

communicating with the Commission

regarding a pending agreement.

Any person filing a comment or

protest with the Commission shall, at

the same time, deliver a copy of that

document to the person filing the

agreement at the address shown below.

Agreement No.: 224–003154–001.

Title: Port of Seattle/Sell Oil Company

Preferential Use Agreement.

Parties:

Port of Seattle

Shell Oil Company (‘‘Shell’’)

Filing Agent: James G. Rice, Senior

Property Manager, Port of Seattle, P.O.

Box 1209, Seattle, WA 98111.

Synopsis: The proposed amendment

authorizes Shell to sell and transfer its

rights and obligations to GATX

Terminal Corporation. It also adds an

annual minimum guarantee and revises

certain payment provisions to the

Agreement.

Dated: February 13, 1995.

By Order of the Federal Maritime

Commission.

Joseph C. Polking,

Secretary.

[FR Doc. 95–3982 Filed 2–16–95; 8:45 am]

BILLING CODE 6730–01–M

Notice of Agreement(s) Filed

The Federal Maritime Commission

hereby gives notice of the filing of the

following agreement(s) pursuant to

section 5 of the Shipping Act of 1984.

Interested parties may inspect and

obtain a copy of each agreement at the

Washington, DC Office of the Federal

Maritime Commission, 800 North
9334 Federal Register / Vol. 60, No. 33 / Friday, February 17, 1995 / Notices

Capitol Street, NW., 9th Floor.

Interested parties may submit comments

on each agreement to the Secretary,

Federal Maritime Commission,

Washington, DC 20573, within 10 days

after the date of the Federal Register in

which this notice appears. The

requirements for comments are found in

§ 572.603 of Title 46 of the Code of

Federal Regulations. Interested persons

should consult this section before

communicating with the Commission

regarding a pending agreement.

Agreement No.: 202–011432–003.

Title: Pacific Latin America

Agreement.

Parties:

Sea-Land Service, Inc.

Central American Container Line,

S.A.

A.P. Moller-Maersk Line

Synopsis: The proposed amendment

deletes Central America Container Line,

S.A., changes the notification period for

independent action from two days to

five days and authorizes the Conference

Chairman or his designee to sign and

file any amendments to the basic

Agreement.

Dated: February 13, 1995.

By Order of the Federal Maritime

Commission.

Joseph C. Polking,

Secretary.

[FR Doc. 95–3981 Filed 2–16–95; 8:45 am]

BILLING CODE 6730–01–M

FEDERAL MARITIME COMMISISON

[Docket No. 95–03]

Puerto Rico Frieght Systems, Inc. v. R

& S Trading and J.C. Trading; Notice

of Filing of Complaint and Assignment

Notice is given that a complaint filed

by Puerto Rico Freight Systems, Inc.

(‘‘Complainant’’) against R & S Trading

and J.C.Trading (‘‘Respondents’’) was

served February 14, 1995. Complainant

alleges that Respondents have violated

sections 3, 14, 15, 16, 17, and 18 of the

Shipping Act of 1916, 46 U.S.C. app.

804, 812, 814, 815, 816 and 817(b)(1), by

issuing false manifests, shipping

materials in containers which are not

manifested or declared by Respondents,

operating without a tariff, waiving fees

for ocean freight, competing with other

freight operators who adhere to a tariff

to their disadvantage, and operating

without bills of lading.

This proceeding has been assigned to

the office of Administrative Law Judges.

Hearing in this matter, if any is held,

shall commence within the time

limitations prescribed in 46 CFR 502.61,

and only after consideration has been

given by the parties and the presiding

officer to the use of alternative forms of

dispute resolution. The hearing shall

include oral testimony and crossexamination in the discretion of the

presiding officer only upon proper

showing that there are genuine issues of

material fact that cannot be resolved on

the basis of sworn statements, affidavits,

depositions, or other documents or that

the nature of the matter in issue is such

that an oral hearing and crossexamination are necessary for the

development of an adequate record.

Pursuant to the further terms of 46 CFR

502.61, the initial decision of the

presiding officer in this proceeding shall

be issued by February 14, 1996, and the

final decision of the Commission shall

be issued by June 14, 1996.

Joseph C. Polking,

Secretary.

[FR Doc. 95–4027 Filed 2–16–95; 8:45 am]

BILLING CODE 6730–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

National Committee on Vital and Health

Statistics: Meeting

Pursuant to Pub. L. 92–463, the

National Center for Health Statistics

(NCHS), Centers for Disease Control and

Prevention (CDC), announces the

following committee meeting.

Name: National Committee on Vital and

Health Statistics (NCVHS).

Times and Dates: 1 p.m.–5 p.m., March 8,

1995; 9 a.m.–5 p.m., March 9, 1995; 9 a.m.–

3 p.m., March 10, 1995.

Place: Room 703A, Hubert H. Humphrey

Building, 200 Independence Avenue, SW,

Washington, D.C. 20201.

Status: Open.

Purpose: The purpose of this meeting is for

the committee to consider reports from each

NCVHS subcommittee; to receive reports

from offices of the Department of Health and

Human Services; to explore information

needs for health reform; and to address new

business as appropriate.

Contact Person for More Information:

Substantive program information as well as

summaries of the meeting and a roster of

committee members may be obtained from

Gail F. Fisher, Ph.D., Executive Secretary,

NCVHS, NCHS, CDC, Room 1100,

Presidential Building, 6525 Belcrest Road,

Hyattsville, Maryland 20782, telephone 301/

436–7050.

Dated: February 13, 1995.

William H. Gimson,

Acting Associate Director for Policy

Coordination, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–3999 Filed 2–16–95; 8:45 am]

BILLING CODE 4163–18–M

Food and Drug Administration

[Docket No. 95M–0023]

Molecular Biosystems, Inc.; Premarket

Approval of Albunex

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing its

approval of the application by

Molecular Biosystems, Inc., San Diego,

CA, for premarket approval, under the

Federal Food, Drug, and Cosmetic Act

(the act), of Albunex. After reviewing

the recommendation of the Radiological

Devices Panel, FDA’s Center for Devices

and Radiological Health (CDRH)

notified the applicant, by letter of

August 5, 1994, of the approval of the

application.

DATES: Petitions for administrative

review by March 20, 1995.

ADDRESSES: Written requests for copies

of the summary of safety and

effectiveness data and petitions for

administrative review to the Dockets

Management Branch (HFA–305), Food

and Drug Administration, rm. 1–23,

12420 Parklawn Dr., Rockville, MD

20857.

FOR FURTHER INFORMATION CONTACT:

Robert Phillips, Center for Devices and

Radiological Health (HFZ–470), Food

and Drug Administration, 9200

Corporate Blvd., Rockville, MD 20850,

301–594–1212.

SUPPLEMENTARY INFORMATION: On

February 5, 1991, Molecular Biosystems,

Inc., San Diego, CA 92121, submitted to

CDRH an application for premarket

approval of Albunex. The device,

which is a suspension of air-filled

microspheres made from sonicated 5

percent human albumin, is an

ultrasound contrast media that is used

as an aid for ultrasound contrast

enhancement of ventricular chambers

and improvement of endocardial border

definition in patients with suboptimal

echoes undergoing ventricular function

and regional wall motion studies.

On July 29, 1992, the Radiological

Devices Panel of the Medical Devices

Advisory Committee, an FDA advisory

committee, reviewed and recommended

approval of the application. On August